15.02USDMkt Cap: 199.85M USDP/E: —Last update: 2026-05-21
Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and ser…
Industry Peers
Drug Manufacturers - Specialty & Genericloading…
Indicators:|
Key Statistics
Company
Market Cap199.85M USD
Enterprise Value184.57M USD
Revenue (TTM)116.26M USD
Gross Profit63.81M USD
Net Income (TTM)-10.88M USD
Revenue/Share8.218 USD
Last Price15.02 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees235
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)32.65
PEG3.69
EV/EBITDA-26.91
EV/Revenue1.59
P/S1.72
P/B1.50
EPS (TTM)-0.79
EPS (Forward)0.46
52W Range
14.8056% of range15.19
52W High15.19 USD
52W Low14.80 USD
Profitability
Gross Margin56.56%
Oper. Margin-18.53%
EBITDA Margin-5.90%
Profit Margin-9.64%
ROE-7.58%
ROA-5.72%
Growth
Revenue Growth13.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF11.19M USD
CapEx (TTM)6.83M USD
FCF Margin5.47%
FCF Yield3.18%
Net Debt-15.28M USD
Net Debt/EBITDA2.23
Balance Sheet
Debt/Equity0.18
Current Ratio4.46
Quick Ratio3.19
Book Value/Sh10.03 USD
Cash/Share3.083 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)17.50 USD
Target Range17.00 USD – 18.00 USD
# Analysts2
Ownership
Shares Out.13.31M
Float11.30M
Insiders5.97%
Institutions94.72%
Short Interest
Short Ratio4.2d
Short % Float5.46%
Short % Out.4.15%
Shares Short552.25K
Short (prev mo.)688.33K
Technical
SMA 5014.77 (+1.7%)
SMA 20011.03 (+36.2%)
Beta0.16
S&P 52W Chg28.31%
Avg Vol (30d)55.70K
Avg Vol (10d)76.42K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—